- Home
- ILMN vs ARE Comparison
ILMN vs ARE Comparison
Compare ILMN & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- ARE
- Stock Information
- Founded
- ILMN 1998
- ARE 1994
- Country
- ILMN United States
- ARE United States
- Employees
- ILMN N/A
- ARE N/A
- Industry
- ILMN Medical Specialities
- ARE Real Estate Investment Trusts
- Sector
- ILMN Health Care
- ARE Real Estate
- Exchange
- ILMN Nasdaq
- ARE Nasdaq
- Market Cap
- ILMN 15.9B
- ARE 17.5B
- IPO Year
- ILMN 2000
- ARE 1997
- Fundamental
- Price
- ILMN $81.88
- ARE $92.36
- Analyst Decision
- ILMN Buy
- ARE Hold
- Analyst Count
- ILMN 18
- ARE 9
- Target Price
- ILMN $141.94
- ARE $120.00
- AVG Volume (30 Days)
- ILMN 2.2M
- ARE 1.2M
- Earning Date
- ILMN 05-01-2025
- ARE 04-28-2025
- Dividend Yield
- ILMN N/A
- ARE 5.72%
- EPS Growth
- ILMN N/A
- ARE 233.15
- EPS
- ILMN N/A
- ARE 1.80
- Revenue
- ILMN $4,372,000,000.00
- ARE $3,123,453,000.00
- Revenue This Year
- ILMN $0.69
- ARE N/A
- Revenue Next Year
- ILMN $4.91
- ARE $3.88
- P/E Ratio
- ILMN N/A
- ARE $51.34
- Revenue Growth
- ILMN N/A
- ARE 8.20
- 52 Week Low
- ILMN $77.54
- ARE $90.07
- 52 Week High
- ILMN $156.66
- ARE $130.14
- Technical
- Relative Strength Index (RSI)
- ILMN 35.35
- ARE 36.52
- Support Level
- ILMN $77.54
- ARE $90.07
- Resistance Level
- ILMN $89.95
- ARE $97.67
- Average True Range (ATR)
- ILMN 2.91
- ARE 2.30
- MACD
- ILMN 0.63
- ARE -0.71
- Stochastic Oscillator
- ILMN 34.97
- ARE 20.54
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.